Leptin and lipid metabolism in chronic kidney failure

Objective. In the general population, leptin has been associated with atherosclerosis and has been shown to interfere with lipoprotein profiles. Patients with chronic renal failure are at increased risk of cardiovascular disease and display alterations in both lipoprotein and leptin levels. The aim...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of clinical and laboratory investigation 2009-01, Vol.69 (3), p.401-408
Main Authors: Kastarinen, H., Kesäniemi, Y. A., Ukkola, O.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Case-Control Studies
Cholesterol
chronic kidney failure
Cross-Sectional Studies
Female
glomerular filtration rate
Humans
Kidney Failure, Chronic - blood
Leptin - blood
Lipids - blood
Lipoproteins - blood
Male
Middle Aged
obesity
triglycerides
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. In the general population, leptin has been associated with atherosclerosis and has been shown to interfere with lipoprotein profiles. Patients with chronic renal failure are at increased risk of cardiovascular disease and display alterations in both lipoprotein and leptin levels. The aim of this study was to investigate the relationship between leptin and the lipoprotein profile in non-dialyzed patients with chronic kidney disease (CKD). Material and methods. Leptin and lipid and lipoprotein concentrations were studied in 73 CKD patients and in 68 healthy controls in a cross-sectional case-control design. Results. The mean leptin levels were increased in the CKD patients (24.0 (SD 37.1) ng mL) compared to those in controls (9.0 (SD 8.5) ng mL) (p = 0.008). Also, the ratio between leptin levels and body mass index (leptin BMI) was increased in CKD patients (mean 0.80 (SD 1.03)) compared to that in controls (0.31 (SD 0.24)) (p = 0.001). In linear regression analysis, leptin independently predicted total cholesterol and triglycerides in CKD patients (p = 0.010 and p = 0.001, respectively) and ratio between total and HDL cholesterol (Chol HDL) in controls (p = 0.024). Furthermore, in CKD patients, the leptin BMI predicted the variation in total cholesterol and triglycerides (p = 0.010 and p = 0.002, respectively). Conclusions. Leptin concentrations and leptin BMI were elevated in CKD patients compared to those in controls. Leptin levels in both study groups, and leptin BMI in the CKD group, were associated with atherogenic lipid profiles, which may contribute to the elevated cardiovascular risk that has been linked to hyperleptinaemia.
ISSN:0036-5513
1502-7686
DOI:10.1080/00365510802706645